218 related articles for article (PubMed ID: 30181285)
1. Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity.
Li H; Fang Y; Niu C; Cao H; Mi T; Zhu H; Yuan J; Zhu J
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9317-E9324. PubMed ID: 30181285
[TBL] [Abstract][Full Text] [Related]
2. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1.
Xu L; Zhu J; Hu X; Zhu H; Kim HT; LaBaer J; Goldberg A; Yuan J
Mol Cell; 2007 Dec; 28(5):914-22. PubMed ID: 18082613
[TBL] [Abstract][Full Text] [Related]
3. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.
Feltham R; Bettjeman B; Budhidarmo R; Mace PD; Shirley S; Condon SM; Chunduru SK; McKinlay MA; Vaux DL; Silke J; Day CL
J Biol Chem; 2011 May; 286(19):17015-28. PubMed ID: 21393245
[TBL] [Abstract][Full Text] [Related]
4. Small molecules destabilize cIAP1 by activating auto-ubiquitylation.
Sekine K; Takubo K; Kikuchi R; Nishimoto M; Kitagawa M; Abe F; Nishikawa K; Tsuruo T; Naito M
J Biol Chem; 2008 Apr; 283(14):8961-8. PubMed ID: 18230607
[TBL] [Abstract][Full Text] [Related]
5. ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth.
Ward GA; Lewis EJ; Ahn JS; Johnson CN; Lyons JF; Martins V; Munck JM; Rich SJ; Smyth T; Thompson NT; Williams PA; Wilsher NE; Wallis NG; Chessari G
Mol Cancer Ther; 2018 Jul; 17(7):1381-1391. PubMed ID: 29695633
[TBL] [Abstract][Full Text] [Related]
6. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
Kim EJ; Kim SH; Jin X; Jin X; Kim H
Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
9. E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding.
Allègre J; Cartier J; Glorian V; Droin N; Dumetier B; Kayaci C; Berthelet J; Gemble S; Vuillier C; Maillet L; Garrido C; Dubrez L
PLoS One; 2018; 13(10):e0206253. PubMed ID: 30359437
[TBL] [Abstract][Full Text] [Related]
10. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the complex regulation of Mad4 in glioblastoma multiforme cells.
Yang W; Yang X; David G; Dorsey JF
Cancer Biol Ther; 2012 Nov; 13(13):1339-48. PubMed ID: 22895069
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
[TBL] [Abstract][Full Text] [Related]
13. The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
Crawford LJ; Campbell DC; Morgan JJ; Lawson MA; Down JM; Chauhan D; McAvera RM; Morris TC; Hamilton C; Krishnan A; Rajalingam K; Chantry AD; Irvine AE
Oncogene; 2020 Jul; 39(27):5001-5014. PubMed ID: 32523091
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
15. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
[TBL] [Abstract][Full Text] [Related]
16. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
[TBL] [Abstract][Full Text] [Related]
17. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-dependent overexpression of c-Myc enhances CRL4
Liu H; Lu W; He H; Wu J; Zhang C; Gong H; Yang C
J Pathol; 2019 Aug; 248(4):464-475. PubMed ID: 30945288
[TBL] [Abstract][Full Text] [Related]
19. Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells.
Yu Z; Li T; Wang C; Deng S; Zhang B; Huo X; Zhang B; Wang X; Zhong Y; Ma X
Oncotarget; 2016 Mar; 7(13):15725-37. PubMed ID: 26894970
[TBL] [Abstract][Full Text] [Related]
20. Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis.
Vu NT; Park MA; Shultz MD; Bulut GB; Ladd AC; Chalfant CE
Cancer Res; 2016 May; 76(10):2977-89. PubMed ID: 27197231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]